Marc Kschonsak

Marc Kschonsak

Auto-generated profile, based on publicly available information

Marc Kschonsak

Genentech Inc, Structural Biology

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Science
Verified
Journal Article
Closed access
ISIndra A. Shaltiel
Indra A. Shaltiel
SDSumanjit Datta
Sumanjit Datta
LLLéa Lecomte
Léa Lecomte
MHMarkus Hassler
Markus Hassler
MKMarc Kschonsak
Marc Kschonsak
CHChristian H. Haering
Christian H. Haering
Structural maintenance of chromosomes (SMC) protein complexes structure genomes by extruding DNA loops, but the molecular mechanism that underlies their activity has remained unknown. We show that the active condensin complex entraps the bases of a DNA loop transiently in two separate chambers. Single-molecule imaging and cryo–electron microscopy suggest a putative power-stroke movement at the first chamber that feeds DNA into the SMC–kleisin ring upon adenosine triphosphate binding, whereas the second chamber holds on upstream of the same DNA double helix. Unlocking the strict separation of “motor” and “anchor” chambers turns condensin from a one-sided into a bidirectional DNA loop extruder. We conclude that the orientation of two topologically bound DNA segments during the SMC reaction cycle determines the directionality of DNA loop extrusion.

1 March 2021 in Cell
Verified
Journal Article
Closed access
MKMarc Kschonsak
Marc Kschonsak
LRLionel Rougé
Lionel Rougé
CAChristopher P. Arthur
Christopher P. Arthur
HHHo Hoangdung
Ho Hoangdung
NPNidhi Patel
Nidhi Patel
CCClaudio Ciferri
Claudio Ciferri

11 March 2022 in Science Advances
Verified
Journal Article
Open access
MKMarc Kschonsak
Marc Kschonsak
MJMatthew C. Johnson
Matthew C. Johnson
RSRachel Schelling
Rachel Schelling
EGEvan M. Green
Evan M. Green
LRLionel Rougé
Lionel Rougé
CCClaudio Ciferri
Claudio Ciferri
Human cytomegalovirus (HCMV) represents the viral leading cause of congenital birth defects and uses the gH/gL/UL128-130-131A complex (Pentamer) to enter different cell types, including epithelial and endothelial cells. Upon infection, Pentamer elicits the most potent neutralizing response against HCMV, representing a key vaccine candidate. Despite its relevance, the structural basis for Pentamer receptor recognition and antibody neutralization is largely unknown. Here, we determine the structures of Pentamer bound to neuropilin 2 (NRP2) and a set of potent neutralizing antibodies against HCMV. Moreover, we identify thrombomodulin (THBD) as a functional HCMV receptor and determine the structures of the Pentamer-THBD complex. Unexpectedly, both NRP2 and THBD also promote dimerization of Pentamer. Our results provide a framework for understanding HCMV receptor engagement, cell entry, antibody neutralization, and outline strategies for antiviral therapies against HCMV.

28 March 2023 in eLife
Verified
Journal Article
Open access
MKMarc Kschonsak
Marc Kschonsak
CJChristine C Jao
Christine C Jao
CAChristopher P Arthur
Christopher P Arthur
ARAlexis L Rohou
Alexis L Rohou
PBPhilippe Bergeron
Philippe Bergeron
JTJohn C Tellis
John C Tellis
The voltage-gated sodium (NaV) channel NaV1.7 has been identified as a potential novel analgesic target due to its involvement in human pain syndromes. However, clinically available NaV channel-blocking drugs are not selective among the nine NaV channel subtypes, NaV1.1–NaV1.9. Moreover, the two currently known classes of NaV1.7 subtype-selective inhibitors (aryl- and acylsulfonamides) have undesirable characteristics that may limit their development. To this point understanding of the structure–activity relationships of the acylsulfonamide class of NaV1.7 inhibitors, exemplified by the clinical development candidate GDC-0310, has been based solely on a single co-crystal structure of an arylsulfonamide inhibitor bound to voltage-sensing domain 4 (VSD4). To advance inhibitor design targeting the NaV1.7 channel, we pursued high-resolution ligand-bound NaV1.7-VSD4 structures using cryogenic electron microscopy (cryo-EM). Here, we report that GDC-0310 engages the NaV1.7-VSD4 through an unexpected binding mode orthogonal to the arylsulfonamide inhibitor class binding pose, which identifies a previously unknown ligand binding site in NaV channels. This finding enabled the design of a novel hybrid inhibitor series that bridges the aryl- and acylsulfonamide binding pockets and allows for the generation of molecules with substantially differentiated structures and properties. Overall, our study highlights the power of cryo-EM methods to pursue challenging drug targets using iterative and high-resolution structure-guided inhibitor design. This work also underscores an important role of the membrane bilayer in the optimization of selective NaV channel modulators targeting VSD4.

11 November 2021 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
IKIlia Kats
Ilia Kats
CRChristian Reinbold
Christian Reinbold
MKMarc Kschonsak
Marc Kschonsak
AKAnton Khmelinskii
Anton Khmelinskii
LALaura Armbruster
Laura Armbruster
MKMichael Knop
Michael Knop
N-terminal acetylation is a prominent protein modification, and inactivation of N-terminal acetyltransferases (NATs) cause protein homeostasis stress. Using multiplexed protein stability profiling with linear ubiquitin fusions as reporters for the activity of the ubiquitin proteasome system, we observed increased ubiquitin proteasome system activity in NatA, but not NatB or NatC mutants. We find several mechanisms contributing to this behavior. First, NatA-mediated acetylation of the N-terminal ubiquitin–independent degron regulates the abundance of Rpn4, the master regulator of the expression of proteasomal genes. Second, the abundance of several E3 ligases involved in degradation of UFD substrates is increased in cells lacking NatA. Finally, we identify the E3 ligase Tom1 as a novel chain-elongating enzyme (E4) involved in the degradation of linear ubiquitin fusions via the formation of branched K11, K29, and K48 ubiquitin chains, independently of the known E4 ligases involved in UFD, leading to enhanced ubiquitination of the UFD substrates.

29 October 2021 in bioRxiv
Verified
Preprint
Open access
ISIndra A. Shaltiel
Indra A. Shaltiel
SDSumanjit Datta
Sumanjit Datta
LLLéa Lecomte
Léa Lecomte
MHMarkus Hassler
Markus Hassler
MKMarc Kschonsak
Marc Kschonsak
CHChristian H. Haering
Christian H. Haering
SMC protein complexes structure genomes by extruding DNA loops, but the molecular mechanism that underlies their activity has remained unknown. We show that the active condensin complex entraps the bases of a DNA loop in two separate chambers. Single-molecule and cryo-electron microscopy provide evidence for a power-stroke movement at the first chamber that feeds DNA into the SMC-kleisin ring upon ATP binding, while the second chamber holds on upstream of the same DNA double helix. Unlocking the strict separation of ‘motor’ and ‘anchor’ chambers turns condensin from a one-sided into a bidirectional DNA loop extruder. We conclude that the orientation of two topologically bound DNA segments during the course of the SMC reaction cycle determines the directionality of DNA loop extrusion.